M&S Decisions attended the ASCO-SITC 2020 Clinical Immuno-Oncology Symposium, Orlando, FL, USA

Kirill Peskov presented the work “Quantification of dose dependence and frequency of checkpoint inhibitor immune-mediated adverse events: A Bayesian model-based meta-analysis” (Abstract №83) at the poster session. A novel meta-analysis methodology was introduced and used to quantify and compare adverse events rates across immune checkpoint inhibitors agents.